Kfir Sharabi et al. screened active components from small molecule libraries to activate the acetylation of liver peroxisome proliferators-activated receptor γ coactivator α (PGC-1α), inhibit hepatic gluconeogenesis, and improve type 2 diabetes (Sharabi et al., 2017). Here, PPARGC1A is linked to type 2 diabetes mellitus.